Borrelli et al. [36] observed that CBG could prevent experimental inflammatory bowel disease in mice by reducing myeloperoxidase activity and inducible nitric oxide synthase (iNOS) expression, and it normalized the levels of the cytokines interleukin (IL)-1β, IL-10, and interferon-γ. This evidence concerns the gene NOS2 and inflammatory bowel disease.